These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5586804)

  • 21. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting].
    Förster W; Gräbner S
    Acta Biol Med Ger; 1966; 16(6):650-7. PubMed ID: 4383660
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of some monoamine oxidase inhibitors on the refractory period of isolated rabbit auricles.
    Bose D
    Indian J Physiol Pharmacol; 1968 Jan; 12(1):63-4. PubMed ID: 5673672
    [No Abstract]   [Full Text] [Related]  

  • 23. Monoamine oxidase inhibitors (MAOI) increase rat brain aromatic amino acid decarboxylase activity.
    Campbell IC; Murphy DL; Walker MN; Lovenberg W; Robinson DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):431-2. PubMed ID: 7378261
    [No Abstract]   [Full Text] [Related]  

  • 24. [Does potentiation of the excito-motor effects of tryptamine in the rat and mouse enable one to measure the action of monoamine oxidase inhibitors?].
    Denys A; Levy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):457-74. PubMed ID: 5850025
    [No Abstract]   [Full Text] [Related]  

  • 25. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of monoamine oxidase inhibitors on the rectal temperature of the rat.
    Summers RJ
    J Pharm Pharmacol; 1974 May; 26(5):335-43. PubMed ID: 4153112
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversibility of MAO inhibition.
    Baxter LR
    J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215
    [No Abstract]   [Full Text] [Related]  

  • 28. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin].
    Mal'tseva LF
    Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590
    [No Abstract]   [Full Text] [Related]  

  • 30. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
    MacKenzie EM; Grant SL; Baker GB; Wood PL
    Neurochem Res; 2008 Mar; 33(3):430-6. PubMed ID: 17768678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of tranylcypromine on glycogenolysis in the rat brain].
    Rinaudo MT; Curto M; Bruno R; Torre E; Bogetto F; Torre M
    Boll Soc Ital Biol Sper; 1979 Jan; 55(2):148-52. PubMed ID: 17955640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptamine: potentiation of its hyperthermic effect in rabbits by various monoamine oxidase inhibitors.
    Quock RM
    Pharmacol Res Commun; 1981 Mar; 13(3):281-6. PubMed ID: 6111091
    [No Abstract]   [Full Text] [Related]  

  • 33. Rat brain concentrations of 5-hydroxytryptamine following acute and chronic administration of MAO-inhibiting antidepressants.
    Baker GB; LeGatt DF; Coutts RT; Dewhurst WG
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):653-6. PubMed ID: 6531436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
    Robinson DS; Campbell IC; Walker M; Statham NJ; Lovenberg W; Murphy DL
    Neuropharmacology; 1979 Oct; 18(10):771-6. PubMed ID: 42024
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of the effects of chronic administration of tranylcypromine and phenelzine on rat brain levels of the catecholamines and their O-methylated metabolites.
    Baker JM; Baker GB; Coutts RT; LeGatt DF
    Proc West Pharmacol Soc; 1983; 26():361-4. PubMed ID: 6889365
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic treatment with phenelzine and other irreversible monoamine oxidase inhibitors downregulates I2-imidazoline receptors in the brain and liver.
    Alemany R; Olmos G; García-Sevilla JA
    Ann N Y Acad Sci; 1995 Jul; 763():506-9. PubMed ID: 7677366
    [No Abstract]   [Full Text] [Related]  

  • 37. Modaline and locomotor activity in the mouse.
    Gylys JA; Muccia PM
    Arch Int Pharmacodyn Ther; 1967 Apr; 166(2):449-65. PubMed ID: 4382254
    [No Abstract]   [Full Text] [Related]  

  • 38. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition.
    Mann JJ
    J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of phenelzine on the content of gamma-aminobutyric acid in 11 regions of the rat brain].
    Popov N; Pohle W; Rösler V; Matthies H
    Acta Biol Med Ger; 1968; 20(3):365-70. PubMed ID: 5725427
    [No Abstract]   [Full Text] [Related]  

  • 40. Potentiation of insulin hypoglycaemia by M.A.O.I. antidepressant drugs.
    Cooper AJ; Ashcroft G
    Lancet; 1966 Feb; 1(7434):407-9. PubMed ID: 4159787
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.